Fisher & Paykel Healthcare said it had raised its net profit by 22 per cent to $64.1 million for the year to March.
The result compared with a net profit of $52.5m, which included one-off non-cash deferred tax charges of $11.5m.
The specialised medical equipment maker said expanding clinical applications for its medical devices and new products contributed to record operating revenue of $516.7m.
In constant currency terms, and excluding the prior year deferred tax charges, the company's net profit after tax grew 23 per cent, mostly as a result of revenue growth, cost control and efficiencies, it said.
The company announced a final dividend of 7c a share, unchanged from the previous final dividend.
